Tag Archives: BPMC

Top 10 Clean Energy Stocks To Watch Right Now

Things are moving fast in renewable energy. Really fast. Consider that in 2008 wind farms supplied just 1.5% of all electricity in the United States. But by 2019 wind power is expected to contribute 6.9% of American electricity and overtake hydropower as the top renewable energy source.

The rise of wind power wouldn’t have been possible without two companies in particular, which combine to own 20.7 gigawatts of wind capacity, or about 24% of the country’s total. Investors wouldn’t be surprised to learn that clean energy provider NextEra Energy is one of the renewable energy stocks most important to American wind power. However, the relatively unheard of natural gas and electric utility Xcel Energy (NASDAQ:XEL) doesn’t seem to garner nearly the same level of attention. Overlooking it could be a mistake.

With 10-year total returns of 226% and plans to grow its dividend and EPS at annual clips of 5% to 7% — all while investing billions in new wind and solar capacity — it could be the best renewable energy stock you’ve never heard of.

Top 10 Clean Energy Stocks To Watch Right Now: AVEO Pharmaceuticals, Inc.(AVEO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By George Budwell]

    Shares of AVEO Pharmaceuticals (NASDAQ:AVEO) gained a healthy 10.7% last month, according to data from S&P Global Market Intelligence. The spark?

  • [By Shane Hupp]

    AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO)’s share price traded down 24.2% during mid-day trading on Tuesday . The company traded as low as $2.15 and last traded at $2.16. 9,547,354 shares traded hands during trading, an increase of 395% from the average session volume of 1,930,275 shares. The stock had previously closed at $2.85.

  • [By Joseph Griffin]

    These are some of the media headlines that may have impacted Accern’s scoring:

    Get AVEO Pharmaceuticals alerts:

    Deadline Upcoming in $15 Million Settlement in the AVEO Pharmaceuticals Inc (NASDAQ:AVEO) Investor Lawsuit (digitaljournal.com) $1.35 Million in Sales Expected for AVEO Pharmaceuticals, Inc. (AVEO) This Quarter (americanbankingnews.com) AVEO Pharmaceuticals, Inc. (AVEO) Expected to Announce Earnings of -$0.06 Per Share (americanbankingnews.com) Equity Opportunities Iv Growth Purchases 236,479 Shares of AVEO Pharmaceuticals, Inc. (AVEO) Stock (americanbankingnews.com) AVEO Pharmaceuticals, Inc. (AVEO) Major Shareholder Buys $392,301.27 in Stock (americanbankingnews.com)

    Several analysts recently weighed in on the company. Zacks Investment Research raised AVEO Pharmaceuticals from a “strong sell” rating to a “hold” rating in a research note on Friday, May 4th. BidaskClub raised AVEO Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Saturday, March 24th. Finally, ValuEngine raised AVEO Pharmaceuticals from a “hold” rating to a “buy” rating in a research note on Wednesday, May 2nd. One investment analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $4.05.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on AVEO Pharmaceuticals (AVEO)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Watch Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    After clinical-stage competitor Loxo Oncology (NASDAQ:LOXO) presented impressive data at the American Society of Clinical Oncology (ASCO) meeting this weekend, shares in Blueprint Medicines (NASDAQ:BPMC) tumbled by as much as 16% on Monday.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Blueprint Medicines (BPMC)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    ValuEngine downgraded shares of Blueprint Medicines (NASDAQ:BPMC) from a strong-buy rating to a buy rating in a report issued on Monday morning.

    BPMC has been the topic of a number of other reports. JMP Securities lowered their price target on Blueprint Medicines from $109.00 to $103.00 and set a buy rating on the stock in a research report on Monday, June 4th. Zacks Investment Research upgraded Blueprint Medicines from a sell rating to a hold rating in a research report on Tuesday, July 3rd. BidaskClub upgraded Blueprint Medicines from a sell rating to a hold rating in a research report on Friday, August 3rd. Finally, Cowen reiterated a buy rating on shares of Blueprint Medicines in a research report on Wednesday, August 1st. Two investment analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of $91.80.

Top 10 Clean Energy Stocks To Watch Right Now: Natural Health Trends Corp.(NHTC)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Natural Health Trends Corp (NASDAQ: NHTC) fell 7.8 percent to $19.80 in pre-market trading after rising 1.46 percent on Friday.
    Endocyte, Inc. (NASDAQ: ECYT) shares fell 6.6 percent to $11.41 in pre-market trading after climbing 4.18 percent on Friday.
    Quorum Health Corporation (NYSE: QHC) shares fell 6.2 percent to $5.15 in pre-market trading after tumbling 11.45 percent on Friday.
    Arcadia Biosciences, Inc. (NASDAQ: RKDA) fell 6.1 percent to $7.31 in pre-market trading after declining 3.35 percent on Friday.
    Boston Scientific Corporation (NYSE: BSX) fell 5.6 percent to $28.30 in pre-market trading.
    Evofem Biosciences, Inc. (NASDAQ: EVFM) fell 5.3 percent to $6.06 in pre-market trading after gaining 2.73 percent on Friday.
    Xerox Corporation (NYSE: XRX) shares fell 5.2 percent to $28.60 in pre-market trading. Xerox terminated its transaction agreement with Fujifilm and entered into a new agreement with Carl Icahn and Darwin Deason. JP Morgan downgraded Xerox from Overweight to Neutral.
    Cellcom Israel Ltd. (NYSE: CEL) fell 5.2 percent to $7.02 in pre-market trading. Cellcom is expected to release Q1 results on May 30, 2018.
    Perrigo Company plc (NYSE: PRGO) fell 4.5 percent to $74 in pre-market trading.
    Nabriva Therapeutics plc (NASDAQ: NBRV) shares fell 4 percent to $4.66 in pre-market trading

  • [By Shane Hupp]

    Natural Health Trends (NASDAQ:NHTC) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research note issued on Friday.

  • [By Max Byerly]

    Central Garden & Pet (NASDAQ: CENT) and Natural Health Trends (NASDAQ:NHTC) are both consumer discretionary companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation.

Top 10 Clean Energy Stocks To Watch Right Now: Xcerra Corporation(XCRA)

Advisors’ Opinion:

  • [By Max Byerly]

    LTX-Credence Co. common stock (NASDAQ:XCRA) – Analysts at B. Riley increased their FY2018 earnings per share estimates for LTX-Credence Co. common stock in a research note issued on Tuesday, May 29th. B. Riley analyst C. Ellis now forecasts that the semiconductor company will post earnings of $1.03 per share for the year, up from their prior estimate of $0.99. B. Riley has a “Neutral” rating and a $14.00 price objective on the stock. B. Riley also issued estimates for LTX-Credence Co. common stock’s Q4 2018 earnings at $0.27 EPS, Q1 2019 earnings at $0.27 EPS, Q2 2019 earnings at $0.23 EPS, Q3 2019 earnings at $0.28 EPS, Q4 2019 earnings at $0.32 EPS, FY2019 earnings at $1.09 EPS and FY2020 earnings at $1.30 EPS.

  • [By Rich Smith]

    “Robust industry trends” in the semiconductor industry, argues Davidson, give this “leading provider of semiconductor test handlers and … emerging player in the associated contactor and vision inspection markets” an “ample runway for growth.” Cohu’s also in the process of acquiring one of its top competitors, Xcerra Corporation (NASDAQ:XCRA), in a deal slated to close next quarter, which will add scale to Cohu’s business even as it removes a source of price competition.

  • [By Ethan Ryder]

    These are some of the news headlines that may have effected Accern Sentiment’s scoring:

    Get LTX-Credence Co. common stock alerts:

    LTX-Credence Co. common stock (XCRA) Receives Consensus Recommendation of “Hold” from Brokerages (americanbankingnews.com) Why Xcerra (XCRA) Could Beat Earnings Estimates Again (finance.yahoo.com) Cohu, Inc. — Moody’s rates Cohu’s CFR at B1; new Senior Secured Term Loan B at B1; outlook stable (finance.yahoo.com) Brokerages Expect LTX-Credence Co. common stock (XCRA) Will Announce Earnings of $0.28 Per Share (americanbankingnews.com)

    XCRA traded down $0.13 during midday trading on Friday, reaching $14.00. The company’s stock had a trading volume of 315,922 shares, compared to its average volume of 270,685. The firm has a market capitalization of $768.81 million, a P/E ratio of 28.57, a price-to-earnings-growth ratio of 1.06 and a beta of 1.46. The company has a quick ratio of 3.35, a current ratio of 4.40 and a debt-to-equity ratio of 0.01. LTX-Credence Co. common stock has a twelve month low of $9.50 and a twelve month high of $14.87.

  • [By Garrett Baldwin]

    Get an exclusive invitation to meet Tim before everyone else right here.

    Three Stocks to Watch Today: LC, GE, GS
    General Electric Co. (NYSE: GE) has ousted its CEO John Flannery. Shares are up more than 10% as investors celebrated the news. GE has been mired in a slump, particularly its turbine business. The firm’s new CEO is H. Lawrence Culp, Jr., the former CEO of the industrial firm Danaher. Shares of LendingClub Corp. (NYSE: LC) are under pressure after the SEC charged one of the firm’s divisions with mishandling client money. This weekend, the firm reached a settlement with regulators on charges that the firm inflated its revenue and made changes to products to make the firm look healthier than it is. As a result, the firm’s board of directors forced CEO Renaud Laplanche to resign. Goldman Sachs Group Inc. (NYSE: GS) has replaced CEO Lloyd Blankfein, who has stepped down after more than a decade at the helm at one of Wall Street’s most iconic banks. David Solomon – who has previously served as the firm’s president and COO – will now bet the new CEO. His tenure begins at a tough time for Goldman as the bank struggles with lower trading desk revenues. Look for earnings reports today from Cal-Maine Foods Inc. (NASDAQ: CALM) and Xcerra Corp. (NASDAQ: XCRA).

    Follow Money Morning on Facebook, Twitter, and LinkedIn.

Top 10 Clean Energy Stocks To Watch Right Now: Equity Commonwealth(EQC)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Neuberger Berman Group LLC lowered its stake in HRPT Properties Trust (NYSE:EQC) by 62.4% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,127 shares of the real estate investment trust’s stock after selling 15,165 shares during the period. Neuberger Berman Group LLC’s holdings in HRPT Properties Trust were worth $307,000 at the end of the most recent quarter.

  • [By ]

    1. Equity Commonwealth (NYSE: EQC)
    It may be surprising to find a real estate investment trust (REIT) on this list, but Sam Zell’s investment vehicle is preparing itself for a possible debt bomb. Zell’s ability to foresee economic trends has built him great wealth. Now, he is selling EQC’s holdings to create a cash hoard ready to deploy when debt causes real estate prices to plunge again.  

  • [By Matthew DiLallo]

    Equity Commonwealth (NYSE:EQC) continued to steadily sell off its portfolio of real estate holdings, closing three more sales during the quarter, bringing its property count down to 13. As a result, cash flow kept declining. That trend doesn’t show any signs of ending given that the company has more properties on the market and doesn’t yet see a good opportunity to make acquisitions. 

  • [By Stephan Byrd]

    HRPT Properties Trust (NYSE:EQC) had its price target boosted by investment analysts at JMP Securities to $33.00 in a report issued on Tuesday. The brokerage currently has a “market outperform” rating on the real estate investment trust’s stock. JMP Securities’ target price points to a potential upside of 4.04% from the company’s previous close.

Top 10 Clean Energy Stocks To Watch Right Now: Infinity Pharmaceuticals, Inc.(INFI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Infinity Pharmaceuticals Inc. (NASDAQ:INFI) CEO Adelene Q. Perkins sold 5,000 shares of Infinity Pharmaceuticals stock in a transaction that occurred on Monday, October 1st. The shares were sold at an average price of $2.82, for a total transaction of $14,100.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

  • [By Logan Wallace]

    ValuEngine upgraded shares of Infinity Pharmaceuticals (NASDAQ:INFI) from a sell rating to a hold rating in a report published on Saturday morning.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Infinity Pharmaceuticals (INFI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Clean Energy Stocks To Watch Right Now: Argo Pantes Tbk PT (ARGO)

Advisors’ Opinion:

  • [By Max Byerly]

    These are some of the news stories that may have impacted Accern’s rankings:

    Get Argo Group alerts:

    Cosgrave Property Group is close to selling its Liberty Shopping Centre in London (thetimes.co.uk) Form 4 Argo Group International For: Sep 05 Filed by: Bullock Jay Stanley (streetinsider.com) Insider Selling: Argo Group (ARGO) CFO Sells 12,323 Shares of Stock (americanbankingnews.com) Argo Blockchain touts promise of cryptos despite falling prices (stockmarketwire.com) Argo Blockchain shrugs off crypto slide and looks long term (proactiveinvestors.co.uk)

    Shares of ARGO traded down $0.30 during midday trading on Friday, hitting $62.95. The stock had a trading volume of 47,644 shares, compared to its average volume of 126,574. Argo Group has a fifty-two week low of $49.69 and a fifty-two week high of $65.90.

  • [By Logan Wallace]

    These are some of the media headlines that may have impacted Accern Sentiment’s scoring:

    Get Argo Group alerts:

    Labour Day game against Tiger-Cats pivotal for Argonauts’ playoff chances (torontosun.com) Argo Group (ARGO) Director John R. Power, Jr. Sells 5,355 Shares (americanbankingnews.com) Keeping supermarket risks in check is a slippery business (insurancebusinessmag.com) Video: ‘Sea Change’ Highlights Female Sailors (bernews.com) Argo names new US specialty programmes leader (intelligentinsurer.com)

    ARGO has been the topic of several research analyst reports. Zacks Investment Research cut shares of Argo Group from a “strong-buy” rating to a “hold” rating in a report on Tuesday, July 10th. Raymond James upped their price target on shares of Argo Group from $65.00 to $68.00 and gave the stock a “strong-buy” rating in a report on Tuesday, May 8th. Finally, Keefe, Bruyette & Woods upped their price target on shares of Argo Group to $69.00 and gave the stock an “outperform” rating in a report on Tuesday, August 7th.

Top 10 Clean Energy Stocks To Watch Right Now: CHS Inc(CHSCL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    CHS (NASDAQ:CHSCL) was upgraded by analysts at BidaskClub from a “strong sell” rating to a “sell” rating in a research report issued on Friday.

Top 10 Clean Energy Stocks To Watch Right Now: Jewett-Cameron Trading Company(JCTCF)

Advisors’ Opinion:

  • [By Max Byerly]

    Media headlines about Jewett-Cameron Trading (NASDAQ:JCTCF) have been trending somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Jewett-Cameron Trading earned a news impact score of 0.08 on Accern’s scale. Accern also gave news coverage about the company an impact score of 45.2200105194978 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the next few days.

  • [By Ethan Ryder]

    Jewett-Cameron Trading Company Ltd (NASDAQ:JCTCF) Director Donald M. Boone sold 3,097 shares of the firm’s stock in a transaction that occurred on Wednesday, September 5th. The shares were sold at an average price of $8.59, for a total value of $26,603.23. Following the completion of the sale, the director now directly owns 1,326,242 shares of the company’s stock, valued at $11,392,418.78. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

  • [By Ethan Ryder]

    Jewett-Cameron Trading Co (NASDAQ:JCTCF) Director Donald M. Boone sold 4,401 shares of the company’s stock in a transaction dated Friday, June 1st. The shares were sold at an average price of $7.89, for a total transaction of $34,723.89. Following the sale, the director now directly owns 1,369,743 shares of the company’s stock, valued at $10,807,272.27. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Top 10 Clean Energy Stocks To Watch Right Now: BP Prudhoe Bay Royalty Trust(BPT)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market had a tumultuous session on Wednesday, as major benchmarks started the day weak but bounced back in the afternoon. Investors weren’t happy with the current state of geopolitical uncertainty, with trade disputes threatening to become larger problems than ever. But the release of the minutes of the latest meeting of the Federal Reserve’s monetary policy committee convinced many that the central bank will be slow to do lasting damage to the economic expansion, remaining measured in the pace of its interest rate increases. Moreover, some companies had good news that sent their shares higher. Tiffany (NYSE:TIF), BP Prudhoe Bay Royalty Trust (NYSE:BPT), and Ralph Lauren (NYSE:RL) were among the best performers on the day. Here’s why they did so well.

  • [By Max Byerly]

    Blockport (CURRENCY:BPT) traded down 4.1% against the dollar during the 1 day period ending at 23:00 PM ET on August 12th. In the last week, Blockport has traded down 26.3% against the dollar. One Blockport token can now be bought for $0.0894 or 0.00001414 BTC on exchanges including Kucoin and IDEX. Blockport has a market capitalization of $4.73 million and approximately $7,133.00 worth of Blockport was traded on exchanges in the last 24 hours.

  • [By Ethan Ryder]

    Blockport (CURRENCY:BPT) traded down 0.3% against the U.S. dollar during the 1-day period ending at 23:00 PM ET on September 14th. One Blockport token can now be bought for $0.0819 or 0.00001261 BTC on popular cryptocurrency exchanges including Kucoin and IDEX. Over the last week, Blockport has traded down 2.3% against the U.S. dollar. Blockport has a total market cap of $4.33 million and $60,265.00 worth of Blockport was traded on exchanges in the last 24 hours.

Top 10 Warren Buffett Stocks To Buy Right Now

Warren Buffett and Jamie Dimon want companies to stop giving quarterly earnings forecasts and focus on the long term. Even investors seeking short-term gains might want to heed their point of view.

You’d think that providing a forecast every three months would make a company’s results more predictable. But since 2016, S&P 500 Index members that provide quarterly outlooks ended up reporting more surprises — or a wider gap between earnings and estimates — than the index as a whole. The group of companies that gave guidance only got closer to the consensus in two of the nine calendar quarters.

Bad Advice

Quarterly guidance has resulted in bigger earnings surprises since 2016

Source: Bloomberg

.chart-js { display: none; }

“Quarterly results are a piece of the investment mosaic, but we find little value in quarterly guidance for active managers performing their own research,” said Christopher Hillary, chief executive officer and portfolio manager at Denver-based Roubaix Capital, the $112 million hedge fund firm that focuses on small-cap stocks. “Long-term goals are a more useful tool in evaluating a business, as well as a means of holding the management and board accountable.”

Top 10 Warren Buffett Stocks To Buy Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Brian Orelli]

    On the downside, Blueprint Medicines (NASDAQ:BPMC)also is developing a RET targeting drug called BLU-667. The company doesn’t seem to be presenting additional data at ASCO, likely because it just released data last month at the American Association for Cancer Research meeting. While it’s very hard to make apples-to-apples comparisons across phase 1 trials, BLU-667 doesn’t look quite as active, with ORR of 50% percent in patients with NSCLC and 40% in patients with medullary thyroid cancer.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

  • [By Todd Campbell]

    In this clip of The Motley Fool’s Industry Focus Healthcare, host Kristine Harjes is joined by Motley Fool contributor Todd Campbell to discuss LOXO-292’s opportunity and how competitor Blueprint Medicines (NASDAQ:BPMC) is challenging it. Also, the two analysts discuss why shares in Abiomed, Inc. (NASDAQ:ABMD) are soaring higher and if this is a high-priced stock that investors should embrace or ignore.

Top 10 Warren Buffett Stocks To Buy Right Now: AmTrust Financial Services, Inc.(AFSI)

Advisors’ Opinion:

  • [By Logan Wallace]

    National General (NASDAQ: NGHC) and AmTrust Financial Services (NASDAQ:AFSI) are both mid-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation and dividends.

  • [By Ethan Ryder]

    Keefe, Bruyette & Woods reissued their $14.58 rating on shares of AmTrust Financial Services (NASDAQ:AFSI) in a research report report published on Wednesday. They currently have a $14.75 price target on the insurance provider’s stock.

  • [By Lisa Levin] Gainers
    Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million.
    Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday.
    LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday.
    Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday.
    AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction.
    Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans.
    PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading.
    TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session.
    IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'.
    Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share.
    The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading.
    PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment.
    Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market

Top 10 Warren Buffett Stocks To Buy Right Now: Magellan Midstream Partners L.P.(MMP)

Advisors’ Opinion:

  • [By John Bromels]

    Three companies that the market has walloped areApache Corporation(NYSE:APA),Magellan Midstream Partners(NYSE:MMP), andGeneral Motors(NYSE:GM). Here’s why these stocks look like bargains, and why today might be a good time to scoop up some shares.

  • [By Reuben Gregg Brewer]

    For an example of just how important this is, take a look at the graph below. Midstream companies ONEOK Inc. (NYSE:OKE), Magellan Midstream Partners LP(NYSE:MMP), and Enterprise Products Partners L.P. (NYSE:EPD) have each increased their disbursements for more than a decade. However, there is a difference in the growth rates over time. Enterprise’s 10-year annualized distribution increase was 5.7%, Magellan’s was 10.9%, and ONEOK’s dividend rose at an annualized 16.1% clip. Just a few percentage points here makes a huge difference in the growth of the disbursement over time, as the chart below clearly shows.

  • [By Reuben Gregg Brewer]

    The midstream partnership sector is deeply out of favor today, despite the fact that these companies provide vital services moving and processing oil and natural gas. For conservative investors, Enterprise Products Partners L.P. (NYSE:EPD) and Magellan Midstream Partners, L.P. (NYSE:MMP) are two high-yield stocks that appear to be on sale today, still off roughly 30% and 20% from their 2014 highs, respectively. Here’s what you need to know to decide if Enterprise or Magellan is the better buy for you.

Top 10 Warren Buffett Stocks To Buy Right Now: Haynes International, Inc.(HAYN)

Advisors’ Opinion:

  • [By Ethan Ryder]

    BidaskClub downgraded shares of Haynes International (NASDAQ:HAYN) from a hold rating to a sell rating in a report released on Saturday morning.

    Several other brokerages have also recently issued reports on HAYN. Zacks Investment Research cut Haynes International from a buy rating to a hold rating and set a $50.00 target price on the stock. in a report on Tuesday, March 13th. ValuEngine raised Haynes International from a hold rating to a buy rating in a report on Thursday, April 19th. One research analyst has rated the stock with a sell rating, one has given a hold rating and three have issued a buy rating to the company’s stock. Haynes International currently has an average rating of Hold and a consensus target price of $35.00.

Top 10 Warren Buffett Stocks To Buy Right Now: STAAR Surgical Company(STAA)

Advisors’ Opinion:

  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) hit a new 52-week high and low during mid-day trading on Friday . The company traded as low as $28.55 and last traded at $28.42, with a volume of 6590 shares changing hands. The stock had previously closed at $27.80.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares jumped 155.56 percent to close at $5.75 on Thursday.
    Inspire Medical Systems, Inc. (NYSE: INSP) shares gained 56.12 percent to close at $24.98. Inspire Medical went public Thursday on the New York Stock Exchange. The company issued 6.75 million shares priced at $16 each.
    Presbia PLC (NASDAQ: LENS) shares rose 53.02 percent to close at $3.55.
    Integrated Media Technology Limited (NASDAQ: IMTE) shares rose 46.29 percent to close at $32.11. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.
    Technical Communications Corporation (NASDAQ: TCCO) climbed 27.78 percent to close at $5.75.
    STAAR Surgical Company (NASDAQ: STAA) shares gained 26.27 percent to close at $21.15 after reporting upbeat Q1 results.
    Sharing Economy International Inc. (NASDAQ: SEII) shares jumped 22.16 percent to close at $4.30 on Thursday after gaining 9.32 percent on Wednesday.
    China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) rose 20.45 percent to close at $2.65 on Thursday.
    YRC Worldwide Inc. (NASDAQ: YRCW) surged 18.36 percent to close at $9.99 following upbeat quarterly earnings.
    MYR Group Inc. (NASDAQ: MYRG) jumped 17.68 percent to close at $35.74 after the company posted strong Q1 earnings.
    Xspand Products Lab Inc (NASDAQ: XSPL) jumped 17.4 percent to close at $5.87. Xspand Products priced its IPO at $5 per share.
    Coherus BioSciences, Inc. (NASDAQ: CHRS) shares rose 17.32 percent to close at $14.90. Coherus BioSciences reported resubmission of BLA for CHS-1701.
    Rudolph Technologies, Inc. (NASDAQ: RTEC) shares gained 17.17 percent to close at $31.05 following upbeat quarterly earnings.
    The Meet Group, Inc. (NASDAQ: MEET) gained 16.02 percent to close at $2.68 following Q1 earnings.
    Ca
  • [By Joseph Griffin]

    STAAR Surgical (NASDAQ:STAA) was upgraded by equities researchers at TheStreet from a “c” rating to a “b-” rating in a research report issued on Monday.

  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 28 percent to $21.40 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 57 percent to $34.52. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

  • [By Lisa Levin]

    STAAR Surgical Company (NASDAQ: STAA) shares shot up 26 percent to $21.03 after reporting upbeat Q1 results.

    Shares of Integrated Media Technology Limited (NASDAQ: IMTE) got a boost, shooting up 56 percent to $34.2425. The nano-cap low-float stock skyrocketed over 1,300 percent on Wednesday on no company specific news which would support the surge. The move higher is consistent with what was seen in other low-float stocks over the past few months.

Top 10 Warren Buffett Stocks To Buy Right Now: ePlus Inc.(PLUS)

Advisors’ Opinion:

  • [By Lisa Levin]

     

    Companies Reporting After The Bell
    Ross Stores, Inc. (NASDAQ: ROST) is projected to post quarterly earnings at $1.07 per share on revenue of $3.54 billion.
    Autodesk, Inc. (NASDAQ: ADSK) is expected to post quarterly earnings at $0.03 per share on revenue of $557.65 million.
    Gap, Inc. (NYSE: GPS) is projected to post quarterly earnings at $0.46 per share on revenue of $3.60 billion.
    Quality Systems, Inc. (NASDAQ: QSII) is estimated to post quarterly earnings at $0.13 per share on revenue of $131.95 million.
    Splunk Inc. (NASDAQ: SPLK) is expected to post quarterly loss at $0.09 per share on revenue of $297.67 million.
    Shoe Carnival, Inc. (NASDAQ: SCVL) is projected to post quarterly earnings at $0.71 per share on revenue of $262.02 million.
    Deckers Outdoor Corporation (NYSE: DECK) is expected to post quarterly earnings at $0.19 per share on revenue of $375.41 million.
    Zoe's Kitchen, Inc. (NYSE: ZOES) is estimated to post quarterly loss at $0.01 per share on revenue of $105.30 million.
    DXC Technology Company (NYSE: DXC) is expected to post quarterly earnings at $2.23 per share on revenue of $6.12 billion.
    8×8, Inc. (NASDAQ: EGHT) is estimated to post quarterly loss at $0.05 per share on revenue of $76.93 million.
    Viasat, Inc. (NASDAQ: VSAT) is projected to post quarterly loss at $0.45 per share on revenue of $424.46 million.
    ePlus inc. (NASDAQ: PLUS) is estimated to post quarterly earnings at $1.01 per share on revenue of $1.60 billion.
    Lions Gate Entertainment Corp. (NYSE: LGF.A) is expected to post quarterly loss at $0.04 per share on revenue of $1.04 billion.
    Agilysys, Inc. (NASDAQ: AGYS) is estimated to post quarterly loss at $0.08 per share on revenue of $32.58 million.
    Nutanix, Inc. (NASDAQ: NTNX) is estimated to post quarterly loss at $0.19 per share on revenue of $278.98 million.
    Veeva Systems Inc. (NYSE: VEEV) is projected to post quarterly earnings at $0.31 per share on revenue

  • [By Ethan Ryder]

    Tech Data (NASDAQ: TECD) and ePlus (NASDAQ:PLUS) are both retail/wholesale companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, analyst recommendations, profitability and earnings.

  • [By Stephan Byrd]

    Teacher Retirement System of Texas decreased its position in ePlus (NASDAQ:PLUS) by 36.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 3,093 shares of the software maker’s stock after selling 1,754 shares during the period. Teacher Retirement System of Texas’ holdings in ePlus were worth $240,000 as of its most recent filing with the SEC.

  • [By ]

    “When and where will all of the many conflicts of interest be listed by the 13 Angry Democrats (plus) working on the Witch Hunt Hoax,” Trump said of the probe on Twitter Thursday. “There has never been a group of people on a case so biased or conflicted. It is all a Democrat Excuse for LOSING the Election.”

  • [By Max Byerly]

    Uniplan Investment Counsel Inc. reduced its stake in ePlus (NASDAQ:PLUS) by 1.1% during the 1st quarter, HoldingsChannel reports. The fund owned 116,594 shares of the software maker’s stock after selling 1,335 shares during the period. Uniplan Investment Counsel Inc.’s holdings in ePlus were worth $9,059,000 at the end of the most recent reporting period.

Top 10 Warren Buffett Stocks To Buy Right Now: Nuveen Tax-Advantaged Total Return Strategy Fund(JTA)

Advisors’ Opinion:

  • [By Max Byerly]

    Wells Fargo & Company MN decreased its holdings in Nuveen Tax Advantaged Total Re (NYSE:JTA) by 48.2% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 10,813 shares of the investment management company’s stock after selling 10,055 shares during the period. Wells Fargo & Company MN owned approximately 0.08% of Nuveen Tax Advantaged Total Re worth $150,000 as of its most recent SEC filing.

Top 10 Warren Buffett Stocks To Buy Right Now: InspireMD, Inc.(NSPR)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Sigma Labs, Inc. (NASDAQ: SGLB) shares rose 90.9 percent to $2.52. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    Oragenics, Inc. (NYSE: OGEN) shares surged 58.4 percent to $1.9005 after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares climbed 23.2 percent to $37.5370 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    Summer Infant, Inc. (NASDAQ: SUMR) rose 21.9 percent to $1.17 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    TapImmune, Inc. (NASDAQ: TPIV) jumped 18.8 percent to $4.87. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Movado Group, Inc. (NYSE: MOV) gained 17.2 percent to $49.45 after the company reported better-than-expected Q1 results and raised its guidance.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) jumped 16.2 percent to $7.96. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Legacy Reserves LP (NASDAQ: LGCY) rose 15.5 percent to $5.6011.
    InspireMD, Inc. (NYSE: NSPR) gained 13.3 percent to $1.36 following PR announcing sustained benefit of CGuard EPS.
    Immutep Limited (NASDAQ: IMMP) shares climbed 13.2 percent to $2.7724 after the company reported new data from its ongoing TACTI-mel Phase I trial, which evaluated the combination of eftilagimod alpha, its lead compound, with Merck & Co., Inc. (NYSE: MRK)'s Keytruda in unresectable or metastatic melanoma patients, who have had a suboptimal response or had disease progression with keytruda monotherapy..
    SpartanNash Co (NASDAQ: SPTN) rose 12.2 percent to $21.20 after the company reported upbeat earnings for its first quarter on Tuesday.
    Amtech Systems, Inc. (NASDAQ: ASYS) rose 12.1 percent to
  • [By Lisa Levin] Gainers
    Oragenics, Inc. (NYSE: OGEN) shares surged 66.67 percent to close at $2.00 on Wednesday after the company’s AG013 for oral mucositis in head and neck cancer patients showed favorable safety profile in mid-stage OM study.
    Sigma Labs, Inc. (NASDAQ: SGLB) shares jumped 49.24 percent to close at $1.97 on Wednesday. Sigma Labs demonstrated proof of concept for closed loop quality control during metal additive manufacturing.
    ASLAN Pharmaceuticals Limited (NASDAQ: ASLN) rose 34.45 percent to close at $9.21. BTIG Research initiated coverage on ASLAN Pharmaceuticals with a Buy rating.
    Dick's Sporting Goods, Inc. (NYSE: DKS) shares rose 25.82 percent to close at $38.35 after the company reported upbeat Q1 earnings and raised FY18 earnings outlook.
    TapImmune, Inc. (NASDAQ: TPIV) rose 24.15 percent to close at $5.09. WBB Securities upgraded TapImmune from Speculative Buy to Buy.
    Legacy Reserves LP (NASDAQ: LGCY) jumped 23.3 percent to close at $5.98 on Wednesday.
    Summer Infant, Inc. (NASDAQ: SUMR) gained 22.92 percent to close at $1.18 after announcing commitment for $60 million credit facility from Bank of America and $17.5 million term loan from Pathlight Capital.
    Cloud Peak Energy Inc. (NYSE: CLD) rose 21.95 percent to close at $4.00.
    SpartanNash Co (NASDAQ: SPTN) gained 21.4 percent to close at $22.92 after the company reported upbeat earnings for its first quarter on Tuesday.
    Motus GI Holdings, Inc. (NASDAQ: MOTS) rose 17.14 percent to close at $5.40.
    Movado Group, Inc. (NYSE: MOV) gained 16.59 percent to close at $49.20 after the company reported better-than-expected Q1 results and raised its guidance.
    Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) climbed 15.61 percent to close at $8.22. Oramed Pharma disclosed that its patent has been allowed in the US for oral administration of proteins.
    Dorian LPG Ltd. (NYSE: LPG) rose 14.89 percent to close at $8.41. Dorian LPG confirmed receipt of unsolicited proposal fr

Top 10 Warren Buffett Stocks To Buy Right Now: Industrias Bachoco, S.A. de C.V.(IBA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Industrias Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Bachoco (NYSE:IBA) declared a semiannual dividend on Thursday, April 26th, NASDAQ reports. Stockholders of record on Friday, May 11th will be given a dividend of 0.432 per share on Monday, May 21st. This represents a dividend yield of 1.53%. The ex-dividend date is Thursday, May 10th. This is a boost from Bachoco’s previous semiannual dividend of $0.42.

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Industrias Bachoco (IBA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Warren Buffett Stocks To Buy Right Now: Can-Fite Biopharma Ltd(CANF)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Co-Diagnostics, Inc. (NASDAQ: CODX) jumped 88 percent to $5.4500 after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) climbed 40.3 percent to $5.40 after the company declared a $0.70 per share special dividend.
    Future FinTech Group Inc. (NASDAQ: FTFT) rose 27 percent to $2.73. Future FinTech disclosed a strategic transformation plan including expanding on current blockchain business while also becoming a blockchain incubator, investment and asset management, training, and management consulting.
    SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) gained 14.7 percent to $5.9522 after the company disclosed that its Phase 2b trial of NeuVax in combo with Trastuzumab in HER1+/2+ breast cancer patients met key clinical objectives.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares climbed 14.6 percent to $120.4224 after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    FTE Networks, Inc. (NASDAQ: FTNW) gained 10.5 percent to $20.9399.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 9 percent to $8.07. Leerink Swann upgraded T2 Biosystems from Market Perform to Outperform.
    Zuora, Inc. (NYSE: ZUO) shares rose 8.3 percent to $24.01 after the company reported upbeat Q1 earnings and issued strong outlook.
    VMware, Inc. (NYSE: VMW) rose 7.7 percent to $148.07 as the company reported stronger-than-expected results for its first quarter on Thursday.
    Ambac Financial Group, Inc. (NASDAQ: AMBC) gained 7.5 percent to $19.91. Ambac Financial will replace Integra Lifesciences Holdings in the S&P SmallCap 600 on Tuesday, June 5.
    Conatus Pharmaceuticals Inc. (NASDAQ: CNAT) gained 7 percent to $4.60.
    Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) climbed 6.6 percent to $18.23.
    Franklin Street Properties Corp. (NYSE: FSP) gained 5.7 perce
  • [By Max Byerly]

    CAN-FITE BIOPHA/S (NYSEAMERICAN:CANF) saw a large drop in short interest in the month of June. As of June 29th, there was short interest totalling 302,241 shares, a drop of 14.1% from the June 15th total of 351,936 shares. Based on an average daily volume of 208,682 shares, the short-interest ratio is presently 1.4 days.

  • [By Lisa Levin] Gainers
    Euro Tech Holdings Company Limited (NASDAQ: CLWT) rose 18.2 percent to $4.55 in pre-market trading after the company declared a $0.70 per share special dividend.
    Co-Diagnostics, Inc. (NASDAQ: CODX) rose 11.7 percent to $3.24 in pre-market trading after falling 13.17 percent on Thursday. Co-Diagnostics reported its participation in a research project with the Stanford University.
    Abercrombie & Fitch Co. (NYSE: ANF) shares rose 8.6 percent to $25.95 in pre-market trading after the company posted upbeat Q1 results.
    Zuora, Inc. (NYSE: ZUO) shares rose 8 percent to $23.95 in pre-market trading after the company reported upbeat Q1 earnings and issued strong outlook.
    Lululemon Athletica Inc. (NASDAQ: LULU) shares rose 7.8 percent to $113.25 in pre-market trading after the company reported better-than-expected results for its first quarter. The company also raised its FY18 earnings and sales guidance.
    OPKO Health, Inc. (NYSE: OPK) rose 5.7 percent to $4.10 in pre-market trading.
    Lannett Company, Inc. (NYSE: LCI) rose 5.5 percent to $17.45 in pre-market trading following the FDA approval for Levofloxacin Oral Solution.
    Eversource Energy (NYSE: ES) shares rose 5 percent to $59.8 in pre-market trading.
    VMware, Inc. (NYSE: VMW) rose 4.6 percent to $143.74 in pre-market trading as the company reported stronger-than-expected results for its first quarter on Thursday.
    Energy Transfer Partners, L.P. (NYSE: ETP) rose 4.3 percent to $19.80 in pre-market trading after the company reported the Federal Energy Regulatory Commission approval to place Rover pipeline’s full Mainline B into service.
    T2 Biosystems, Inc. (NASDAQ: TTOO) rose 4.3 percent to $7.73 in pre-market trading after declining 4.26 percent on Thursday.
    Curis, Inc. (NASDAQ: CRIS) rose 4.3 percent to $2.90 in pre-market trading after jumping 21.93 percent on Thursday.
    Sasol Limited (NYSE: SSL) rose 4.2 percent to $37.91 in pre-market trading.
    Nucor Corporatio
  • [By Shane Hupp]

    Press coverage about Can-Fite Biopharma (NASDAQ:CANF) has trended somewhat positive this week, Accern reports. The research group identifies positive and negative news coverage by monitoring more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Can-Fite Biopharma earned a media sentiment score of 0.24 on Accern’s scale. Accern also gave press coverage about the company an impact score of 45.2576556193403 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

Best High Tech Stocks To Own For 2019

Equities research analysts forecast that Allegiant Travel (NASDAQ:ALGT) will report earnings per share (EPS) of $2.72 for the current quarter, according to Zacks. Four analysts have provided estimates for Allegiant Travel’s earnings. The lowest EPS estimate is $2.40 and the highest is $3.25. Allegiant Travel posted earnings of $2.94 per share during the same quarter last year, which would indicate a negative year-over-year growth rate of 7.5%. The business is scheduled to announce its next quarterly earnings results on Wednesday, July 25th.

On average, analysts expect that Allegiant Travel will report full year earnings of $10.91 per share for the current year, with EPS estimates ranging from $10.42 to $11.35. For the next year, analysts expect that the business will report earnings of $14.10 per share, with EPS estimates ranging from $12.75 to $15.87. Zacks’ earnings per share averages are an average based on a survey of sell-side research analysts that cover Allegiant Travel.

Best High Tech Stocks To Own For 2019: Chuy's Holdings, Inc.(CHUY)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about Chuy’s (NASDAQ:CHUY) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies positive and negative news coverage by monitoring more than twenty million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Chuy’s earned a coverage optimism score of 0.17 on Accern’s scale. Accern also assigned news articles about the restaurant operator an impact score of 45.384946677215 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the next several days.

  • [By Shane Hupp]

    Arcos Dorados (NYSE: ARCO) and Chuy’s (NASDAQ:CHUY) are both small-cap retail/wholesale companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, risk, institutional ownership, earnings, profitability, valuation and analyst recommendations.

  • [By Logan Wallace]

    ValuEngine upgraded shares of Chuy’s (NASDAQ:CHUY) from a hold rating to a buy rating in a research report released on Thursday morning.

    A number of other equities analysts also recently commented on CHUY. Telsey Advisory Group reissued a market perform rating and set a $29.00 price objective (up from $23.00) on shares of Chuy’s in a research report on Wednesday, February 28th. BidaskClub raised Chuy’s from a hold rating to a buy rating in a research report on Tuesday, March 6th. Zacks Investment Research downgraded Chuy’s from a buy rating to a hold rating in a research report on Tuesday, March 6th. Wedbush reissued a hold rating and set a $25.00 price objective on shares of Chuy’s in a research report on Friday, March 9th. Finally, BMO Capital Markets reissued a hold rating and set a $27.00 price objective (down from $30.00) on shares of Chuy’s in a research report on Friday, March 9th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, three have issued a buy rating and one has issued a strong buy rating to the stock. The stock currently has an average rating of Hold and an average target price of $27.22.

  • [By Joseph Griffin]

    Chuy’s (NASDAQ:CHUY) had its price target hoisted by BMO Capital Markets from $27.00 to $28.00 in a report published on Wednesday, Marketbeat.com reports. The firm currently has a hold rating on the restaurant operator’s stock.

Best High Tech Stocks To Own For 2019: Expeditors International of Washington, Inc.(EXPD)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    Dean Foods Company (NYSE: DF) is projected to report quarterly earnings at $0.11 per share on revenue of $1.85 billion.
    Discovery, Inc. (NASDAQ: DISCA) is expected to report quarterly earnings at $0.44 per share on revenue of $1.99 billion.
    Jacobs Engineering Group Inc. (NYSE: JEC) is estimated to report quarterly earnings at $0.89 per share on revenue of $3.63 billion.
    Henry Schein, Inc. (NASDAQ: HSIC) is expected to report quarterly earnings at $0.92 per share on revenue of $3.17 billion.
    Gartner, Inc. (NYSE: IT) is projected to report quarterly earnings at $0.57 per share on revenue of $926.18 million.
    The AES Corporation (NYSE: AES) is estimated to report quarterly earnings at $0.24 per share on revenue of $2.98 billion.
    Expeditors International of Washington, Inc. (NASDAQ: EXPD) is projected to report quarterly earnings at $0.64 per share on revenue of $1.71 billion.
    US Foods Holding Corp. (NYSE: USFD) is expected to report quarterly earnings at $0.32 per share on revenue of $5.98 billion.
    DISH Network Corporation (NASDAQ: DISH) is expected to report quarterly earnings at $0.7 per share on revenue of $3.50 billion.
    Zebra Technologies Corporation (NASDAQ: ZBRA) is estimated to report quarterly earnings at $2.06 per share on revenue of $936.98 million.
    Camping World Holdings, Inc. (NYSE: CWH) is expected to report quarterly earnings at $0.42 per share on revenue of $1.06 billion.
    Perrigo Company plc (NYSE: PRGO) is projected to report quarterly earnings at $1.14 per share on revenue of $1.21 billion.
    Petróleo Brasileiro S.A. – Petrobras (NYSE: PBR) is estimated to report quarterly earnings at $0.28 per share on revenue of $23.80 billion.
    JD.com, Inc. (NYSE: JD) is projected to report quarterly earnings at $0.18 per share on revenue of $15.65 billion.
    Valeant Pharmaceuticals International, Inc. (NYSE: VRX) is projected to report quarterly earnings at $0.6 per share o
  • [By Joseph Griffin]

    Expeditors International of Washington (NASDAQ:EXPD) has been assigned a consensus recommendation of “Hold” from the eleven research firms that are covering the company, Marketbeat reports. Three analysts have rated the stock with a sell recommendation, five have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $65.63.

  • [By Max Byerly]

    The Manufacturers Life Insurance Company boosted its stake in shares of Expeditors International of Washington (NASDAQ:EXPD) by 22.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 240,918 shares of the transportation company’s stock after purchasing an additional 44,645 shares during the period. The Manufacturers Life Insurance Company owned approximately 0.14% of Expeditors International of Washington worth $15,249,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    Adviser Investments LLC trimmed its holdings in Expeditors International of Washington (NASDAQ:EXPD) by 78.8% in the first quarter, HoldingsChannel.com reports. The fund owned 2,550 shares of the transportation company’s stock after selling 9,500 shares during the period. Adviser Investments LLC’s holdings in Expeditors International of Washington were worth $161,000 at the end of the most recent quarter.

  • [By Stephan Byrd]

    News articles about Expeditors International of Washington (NASDAQ:EXPD) have been trending somewhat positive this week, Accern reports. The research group identifies positive and negative press coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Expeditors International of Washington earned a media sentiment score of 0.15 on Accern’s scale. Accern also assigned media headlines about the transportation company an impact score of 46.7570916317495 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Dan Caplinger]

    Tuesday saw an up-and-down session on Wall Street, with major benchmarks trading on either side of the unchanged mark before finishing the day flat. Many investors kept most of their attention on Washington, where the White House announced that the U.S. would withdraw from the deal that the previous administration made with Iran concerning nuclear development. The withdrawal was largely expected, and although crude oil and other commodities were volatile leading up to the final decision, most other financial markets seemed prepared for the announcement. Even on a lackluster day, some companies had good news that lifted their shares substantially. Expeditors International of Washington (NASDAQ:EXPD), Valeant Pharmaceuticals International (NYSE:VRX), and SeaWorld Entertainment (NYSE:SEAS) were among the best performers on the day. Here’s why they did so well.

Best High Tech Stocks To Own For 2019: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

  • [By Ethan Ryder]

    Northern Trust Corp boosted its position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 0.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 497,135 shares of the biotechnology company’s stock after acquiring an additional 726 shares during the period. Northern Trust Corp owned 1.13% of Blueprint Medicines worth $45,588,000 at the end of the most recent quarter.

Best High Tech Stocks To Own For 2019: Packaging Corporation of America(PKG)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Packaging Corp Of America (NYSE:PKG) was the target of some unusual options trading on Wednesday. Stock investors acquired 1,456 call options on the stock. This represents an increase of 804% compared to the average volume of 161 call options.

  • [By Ethan Ryder]

    Swiss National Bank lowered its stake in Packaging Co. of America (NYSE:PKG) by 13.1% in the first quarter, Holdings Channel reports. The institutional investor owned 301,500 shares of the industrial products company’s stock after selling 45,500 shares during the period. Swiss National Bank’s holdings in Packaging Co. of America were worth $33,979,000 as of its most recent filing with the Securities and Exchange Commission.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Packaging Corp Of America (PKG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Asit Sharma]

    One of the most effective tenets of manufacturing is to increase capacity where demand is sustained, and to carefully contract production where demand has dimmed. This summer, Packaging Corp of America (NYSE:PKG) is living by this philosophy, completing a major conversion of the company’s No. 3 machine at its Wallula, Washington mill. The machine will be converted from a paper outputting unit to a packaging beast, which CEO Mark Kowlzan describes as a “400,000 ton per year, high performance, 100% virgin kraft linerboard machine.”

  • [By Ethan Ryder]

    Sonoco (NYSE: SON) and Packaging Co. of America (NYSE:PKG) are both industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation.

  • [By Ethan Ryder]

    Mackay Shields LLC purchased a new position in shares of Packaging Co. of America (NYSE:PKG) in the 1st quarter, HoldingsChannel.com reports. The firm purchased 15,881 shares of the industrial products company’s stock, valued at approximately $1,790,000.

Best High Tech Stocks To Own For 2019: Just Energy Group, Inc.(JE)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Canaccord Genuity lowered shares of Just Energy (NYSE:JE) (TSE:JE) from a buy rating to a hold rating in a report issued on Thursday morning. Canaccord Genuity currently has $3.86 price objective on the utilities provider’s stock.

  • [By Stephan Byrd]

    Shares of Just Eat PLC (LON:JE) have earned a consensus recommendation of “Buy” from the sixteen brokerages that are presently covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a sell recommendation, three have issued a hold recommendation, nine have given a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is GBX 844.62 ($11.33).

  • [By Shane Hupp]

    News articles about Just Energy Group (NYSE:JE) (TSE:JE) have been trending somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of news coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Just Energy Group earned a daily sentiment score of 0.21 on Accern’s scale. Accern also gave media stories about the utilities provider an impact score of 44.690499827081 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.

  • [By Lisa Levin]

    Just Energy Group Inc. (NYSE: JE) is projected to post quarterly earnings at $0.15 per share on revenue of $873.77 million.

    Dynagas LNG Partners LP (NYSE: DLNG) is expected to post quarterly earnings at $0.15 per share on revenue of $34.49 million.

Best High Tech Stocks To Own For 2019: Attunity Ltd.(ATTU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Attunity (ATTU)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Attunity Ltd (NASDAQ:ATTU) has earned an average recommendation of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat reports. Four investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have covered the stock in the last year is $12.33.

Top Warren Buffett Stocks To Own Right Now

When stock markets turn volatile many investors find it difficult to stay the course. Some investors want to sell off and want to hoard their cash. Some prefer to start buying the stocks that are falling the most. But such knee-jerk reactions may not create wealth for you. Here are five thoughts of Warren Buffett that may guide you in your investment actions in such volatile times.

It’s far better to buy a wonderful company at a fair price than a fair company at a wonderful price.

Quality matters. Just because a company has fallen 20% from its 52 week high does not make it a great value buy. Do check the fundamentals of the company. Corrections in the market must be used to buy quality stocks for your long term portfolio. Buying them at a fair price makes sense for long term investors. Good businesses tend to compound their profits and reward the shareholders in the long term. Stick to companies that have exhibited decent business performance across business cycles.

Picking up the micro-cap stocks with great potentials may not reward you if the stories do not materialise as expected. If you have a dud stock in your portfolio, use the spikes to get rid of it. Use the proceeds to buy fundamentally strong companies.

Top Warren Buffett Stocks To Own Right Now: Universal Stainless & Alloy Products, Inc.(USAP)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Universal Stainless & Alloy Products (USAP)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Shares of Universal Stainless & Alloy Products, Inc. (NASDAQ:USAP) traded down 0% on Friday . The company traded as low as $24.22 and last traded at $24.53. 505,097 shares were traded during trading, an increase of 1,278% from the average session volume of 36,661 shares. The stock had previously closed at $24.53.

  • [By Ethan Ryder]

    Universal Stainless & Alloy Products (NASDAQ: USAP) and SUMITOMO Corp/S (OTCMKTS:SSUMY) are both basic materials companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, risk, dividends, earnings and analyst recommendations.

Top Warren Buffett Stocks To Own Right Now: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Logan Wallace]

    News articles about PDC Energy (NASDAQ:PDCE) have trended somewhat positive this week, Accern reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. PDC Energy earned a news impact score of 0.12 on Accern’s scale. Accern also gave news articles about the energy producer an impact score of 46.6251700229584 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Get a free copy of the Zacks research report on PDC Energy (PDCE)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top Warren Buffett Stocks To Own Right Now: Sandy Spring Bancorp, Inc.(SASR)

Advisors’ Opinion:

  • [By Max Byerly]

    MetLife Investment Advisors LLC lifted its holdings in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 38.5% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,587 shares of the bank’s stock after buying an additional 4,054 shares during the period. MetLife Investment Advisors LLC’s holdings in Sandy Spring Bancorp were worth $565,000 at the end of the most recent quarter.

  • [By Joseph Griffin]

    LSV Asset Management cut its stake in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 3.4% in the 1st quarter, Holdings Channel reports. The fund owned 92,100 shares of the bank’s stock after selling 3,200 shares during the quarter. LSV Asset Management’s holdings in Sandy Spring Bancorp were worth $3,569,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Logan Wallace]

    Maltese Capital Management LLC raised its position in shares of Sandy Spring Bancorp Inc. (NASDAQ:SASR) by 230.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 330,712 shares of the bank’s stock after acquiring an additional 230,611 shares during the quarter. Maltese Capital Management LLC owned approximately 0.93% of Sandy Spring Bancorp worth $12,818,000 as of its most recent SEC filing.

  • [By Max Byerly]

    Sandy Spring Bancorp Inc. (NASDAQ:SASR) Director Joseph S. Bracewell sold 32,173 shares of the stock in a transaction dated Wednesday, June 6th. The shares were sold at an average price of $43.36, for a total transaction of $1,395,021.28. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.

  • [By Shane Hupp]

    News articles about Sandy Spring Bancorp (NASDAQ:SASR) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Sandy Spring Bancorp earned a daily sentiment score of 0.10 on Accern’s scale. Accern also gave news headlines about the bank an impact score of 44.8977197847726 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

  • [By Stephan Byrd]

    Sandy Spring Bancorp Inc. (NASDAQ:SASR) Director Mark C. Michael sold 1,000 shares of the company’s stock in a transaction that occurred on Friday, May 18th. The stock was sold at an average price of $41.30, for a total value of $41,300.00. Following the transaction, the director now directly owns 81,590 shares of the company’s stock, valued at $3,369,667. The sale was disclosed in a filing with the SEC, which is available through the SEC website.

Top Warren Buffett Stocks To Own Right Now: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Todd Campbell]

    After clinical-stage competitor Loxo Oncology (NASDAQ:LOXO) presented impressive data at the American Society of Clinical Oncology (ASCO) meeting this weekend, shares in Blueprint Medicines (NASDAQ:BPMC) tumbled by as much as 16% on Monday.

  • [By Todd Campbell]

    The big thing to watch this week will be how investors view Loxo’s results in comparison to results presented earlier this year by Blueprint Medicines (NASDAQ:BPMC). Blueprint’s BLU-667 also targets RET-fusions and at the American Association for Cancer Research meeting in April, Blueprint revealed a preliminary overall response rate of 50% for NSCLC and 40% for MTC. It’s bad science to compare unrelated trials, so investors might be best off viewing Loxo and Blueprint’s data as evidence that they’re both working on a winning approach.

  • [By Ethan Ryder]

    Northern Trust Corp boosted its position in shares of Blueprint Medicines Corp (NASDAQ:BPMC) by 0.1% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 497,135 shares of the biotechnology company’s stock after acquiring an additional 726 shares during the period. Northern Trust Corp owned 1.13% of Blueprint Medicines worth $45,588,000 at the end of the most recent quarter.

  • [By Todd Campbell]

    In this clip of The Motley Fool’s Industry Focus Healthcare, host Kristine Harjes is joined by Motley Fool contributor Todd Campbell to discuss LOXO-292’s opportunity and how competitor Blueprint Medicines (NASDAQ:BPMC) is challenging it. Also, the two analysts discuss why shares in Abiomed, Inc. (NASDAQ:ABMD) are soaring higher and if this is a high-priced stock that investors should embrace or ignore.

  • [By Todd Campbell]

    Investors should also keep their enthusiasm in check because Loxo Oncology isn’t alone in targeting TRK fusion and RET mutations:Roche Holdings (NASDAQOTH:RHHBY) could challenge it in TRK fusions and Blueprint Medicines (NASDAQ:BPMC) could compete with it in RET mutations.

Hot Medical Stocks To Buy For 2019

Image source: Getty Images.

What happened

Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

So what

The drug delivery specialist didn’t release any news on Friday that could justify its big move.Instead, Insulet’s stock appears to be rising in response to goodnews that was released by one of the company’s partners.

DexCom (NASDAQ:DXCM), a diabetes-focused company that makes continuous glucose monitors, announced on Thursday evening that theCenters for Medicare & Medicaid Services (CMS) has officially decided to cover its G5 Mobilesystem.

DexCom’s CEO Kevin Sayer was thrilled with the news, stating, “This landmark CMS Ruling will make available the most important technology in diabetes management to theMedicarepopulation.”

Hot Medical Stocks To Buy For 2019: Trinity Industries Inc.(TRN)

Advisors’ Opinion:

  • [By Craig Jones]

    On CNBC's "Fast Money Halftime Report", Pete Najarian spoke about high options activity in Trinity Industries Inc (NYSE: TRN).

    He said that options traders bought 5,200 contracts of the January 36 calls for $1.15 in the first half of the trading session. The trade breaks even at $37.15 or 3.17 percent above the closing price Monday. Najarian believes the stock is going to break out on the upside and he decided to follow the trade and buy the January calls. He is going to hold the position for two weeks.

  • [By Lisa Levin]

    Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades were initially published intraday in Benzinga Professional . These trades were placed during Thursday’s regular session.

  • [By ]

    5. Trinity Industries (NYSE: TRN)
    This industrial company is trading lower by over 15% in 2018. A substantial shareholder named Valueact Holdings has purchased over one million shares in the $32.00 range.

  • [By Jon C. Ogg]

    Also seen aswinners are equipment and fixtures makers, from construction to rail to transports. Trinity Industries Inc. (NYSE: TRN), largely considered a rail winner, was up 1.4% at $27.20 late on Monday.

Hot Medical Stocks To Buy For 2019: PDC Energy, Inc.(PDCE)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Goldman Sachs analyst Brian Singer and team contend that EOG Resources (EOG), Diamondback Energy (FANG), PDC Energy (PDCE), Pioneer Natural Resources (PXD), and RSP Permian (RSPP) can benefit from greater productivity. They explain:

  • [By Ben Levisohn]

    Names which screen well on a combination of attractive valuation and equitized capital structure, include Outperform rated Apache, Anadarko Petroleum,Gulfport Energy as well as Market Perform rated QEP Resources (QEP) and PDC Energy (PDCE).

Hot Medical Stocks To Buy For 2019: Blueprint Medicines Corporation(BPMC)

Advisors’ Opinion:

  • [By Shane Hupp]

    A number of hedge funds and other institutional investors have recently added to or reduced their stakes in BPMC. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Blueprint Medicines by 57.3% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,866 shares of the biotechnology company’s stock valued at $141,000 after acquiring an additional 680 shares in the last quarter. QS Investors LLC acquired a new position in Blueprint Medicines in the 4th quarter valued at about $173,000. First Mercantile Trust Co. acquired a new position in Blueprint Medicines in the 4th quarter valued at about $183,000. Tower Research Capital LLC TRC grew its position in Blueprint Medicines by 942.7% in the 4th quarter. Tower Research Capital LLC TRC now owns 2,513 shares of the biotechnology company’s stock valued at $190,000 after acquiring an additional 2,272 shares in the last quarter. Finally, Public Employees Retirement Association of Colorado acquired a new position in Blueprint Medicines in the 4th quarter valued at about $227,000. 97.79% of the stock is owned by institutional investors.

    COPYRIGHT VIOLATION NOTICE: “BidaskClub Downgrades Blueprint Medicines (BPMC) to Hold” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this report on another site, it was illegally stolen and reposted in violation of international trademark & copyright law. The legal version of this report can be read at www.tickerreport.com/banking-finance/3356624/bidaskclub-downgrades-blueprint-medicines-bpmc-to-hold.html.

    Blueprint Medicines Company Profile